These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20624761)

  • 1. Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases.
    Merino M; Pérez-Llarena FJ; Kerff F; Poza M; Mallo S; Rumbo-Feal S; Beceiro A; Juan C; Oliver A; Bou G
    J Antimicrob Chemother; 2010 Sep; 65(9):1950-4. PubMed ID: 20624761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on: role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases.
    Castanheira M; Deshpande LM; Mendes RE; Rodriguez-Noriega E; Jones RN; Morfin-Otero R
    J Antimicrob Chemother; 2011 Mar; 66(3):684-5; author reply 686. PubMed ID: 20961909
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural and computational investigations of VIM-7: insights into the substrate specificity of vim metallo-β-lactamases.
    Borra PS; Leiros HK; Ahmad R; Spencer J; Leiros I; Walsh TR; Sundsfjord A; Samuelsen O
    J Mol Biol; 2011 Aug; 411(1):174-89. PubMed ID: 21645522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167.
    Kimura S; Ishii Y; Tateda K; Yamaguchi K
    Int J Antimicrob Agents; 2007 Mar; 29(3):326-31. PubMed ID: 17258896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases.
    Delmas J; Chen Y; Prati F; Robin F; Shoichet BK; Bonnet R
    J Mol Biol; 2008 Jan; 375(1):192-201. PubMed ID: 17999931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and biochemical characterization of VIM-12, a novel hybrid VIM-1/VIM-2 metallo-beta-lactamase from a Klebsiella pneumoniae clinical isolate, reveal atypical substrate specificity.
    Kontou M; Pournaras S; Kristo I; Ikonomidis A; Maniatis AN; Stathopoulos C
    Biochemistry; 2007 Nov; 46(45):13170-8. PubMed ID: 17944487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New mutations in ADC-type β-lactamases from Acinetobacter spp. affect cefoxitin and ceftazidime hydrolysis.
    Pérez A; Pérez-Llarena FJ; García P; Kerff F; Beceiro A; Galleni M; Bou G
    J Antimicrob Chemother; 2014 Sep; 69(9):2407-11. PubMed ID: 24845871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tripeptide deletion in the R2 loop of the class C beta-lactamase enzyme FOX-4 impairs cefoxitin hydrolysis and slightly increases susceptibility to beta-lactamase inhibitors.
    Mallo S; Pérez-Llarena FJ; Kerff F; Soares NC; Galleni M; Bou G
    J Antimicrob Chemother; 2010 Jun; 65(6):1187-94. PubMed ID: 20382725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three factors that modulate the activity of class D β-lactamases and interfere with the post-translational carboxylation of Lys70.
    Vercheval L; Bauvois C; di Paolo A; Borel F; Ferrer JL; Sauvage E; Matagne A; Frère JM; Charlier P; Galleni M; Kerff F
    Biochem J; 2010 Dec; 432(3):495-504. PubMed ID: 21108605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
    Samuelsen Ø; Castanheira M; Walsh TR; Spencer J
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2905-8. PubMed ID: 18559652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase.
    Banerjee S; Pieper U; Kapadia G; Pannell LK; Herzberg O
    Biochemistry; 1998 Mar; 37(10):3286-96. PubMed ID: 9521648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4.
    Lassaux P; Traoré DA; Loisel E; Favier A; Docquier JD; Sohier JS; Laurent C; Bebrone C; Frère JM; Ferrer JL; Galleni M
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1248-55. PubMed ID: 21149620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.
    Raquet X; Lamotte-Brasseur J; Fonzé E; Goussard S; Courvalin P; Frère JM
    J Mol Biol; 1994 Dec; 244(5):625-39. PubMed ID: 7990143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Drug-Resistant Variant P167S Expands the Substrate Profile of CTX-M β-Lactamases for Oxyimino-Cephalosporin Antibiotics by Enlarging the Active Site upon Acylation.
    Patel MP; Hu L; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
    Biochemistry; 2017 Jul; 56(27):3443-3453. PubMed ID: 28613873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS; Ishii Y; Galleni M; Ishiguro M; Yamaguchi K; Frère JM; Matsuzawa H; Sakai H
    Biochemistry; 2003 Sep; 42(36):10634-43. PubMed ID: 12962487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. His224 alters the R2 drug binding site and Phe218 influences the catalytic efficiency of the metallo-β-lactamase VIM-7.
    Leiros HK; Skagseth S; Edvardsen KS; Lorentzen MS; Bjerga GE; Leiros I; Samuelsen Ø
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4826-36. PubMed ID: 24913158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and kinetics of the beta-lactamase mutants S70A and K73H from Staphylococcus aureus PC1.
    Chen CC; Smith TJ; Kapadia G; Wäsch S; Zawadzke LE; Coulson A; Herzberg O
    Biochemistry; 1996 Sep; 35(38):12251-8. PubMed ID: 8823158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop.
    Poirel L; Naas T; Le Thomas I; Karim A; Bingen E; Nordmann P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3355-61. PubMed ID: 11709308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.